ALLO Earnings Preview: Options Price a ±24.4% Move
· The NYC Memo · ALLO reports 2026-11-05
Allogene Therapeutics, Inc. reports November 5, 2026. The November 20, 2026 straddle implies ±24.37% against a 6.58% average reaction, with dealers long gamma and max pain at $1.
Allogene Therapeutics, Inc. reports Q3 2026 results on November 5, 2026, after close. The November 20, 2026 straddle is priced at $0.29, an implied move of ±24.37% against an average realised reaction of 6.58% over the last 8 prints. The stock trades at $1.19, -73.3% from its 52-week high, with dealers long gamma and max pain at $1.
What the options market is pricing
| Measure | Level |
|---|---|
| November 5, 2026, After Close | |
| Expiry used | November 20, 2026 (15 days out) |
| Spot | $1.19 |
| ATM straddle | $0.29 |
| Implied move | ±24.37% ($0.90 to $1.48) |
| ATM implied vol | 166.1% |
| Put/call open interest | 0.13 |
| Max pain | $1 |
| Net dealer gamma | +$0.01mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $2 (3,030 contracts) |
| Heaviest put strike below spot | $0.5 (4 contracts) |
| Street EPS estimate | $-0.15 |
| Street revenue estimate | $0.00bn |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ALLO between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 12 | -4.35% |
| Q1 2026, May 13 | -8.15% |
| Q4 2025, Mar 12 | -2.83% |
| Q3 2025, Nov 6 | +12.38% |
| Q2 2025, Aug 13 | +2.88% |
| Q1 2025, May 13 | -15.93% |
| Q4 2024, Mar 13 | +2.65% |
| Q3 2024, Nov 7 | -3.45% |
Across the last 8 prints the average absolute reaction is 6.58%, with 3 higher and 5 lower. The best was +12.38% and the worst -15.93%. Options are asking ±24.37%, which is 17.79 points richer than the realised average, the premium seller's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $1.19 |
| 52-week range | $1.04 to $4.46 |
| Position in that range | 4% |
| From the 52-week high | -73.3% |
| From the 52-week low | +14.4% |
| Past week | -8.5% |
| Past month | -18.5% |
| Past three months | -39.6% |
| 50-day average | $1.56 |
| 200-day average | $1.97 |
How the options market is pricing it
The November 20, 2026 straddle marks $0.90 to $1.48 as the range the options market is paying for into the print, with ATM implied vol at 166% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ALLO has moved 6.58% on earnings against the ±24.37% now implied, so the market is pricing this print richer than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ALLO before the print.
Data as of November 5, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ALLO options memo